CIK 0001420565
- Non-accelerated filer
- Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 134196017
- Phone
- +1 737-802-1989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-25 | Dougherty Donald SVP & Chief Financial Officer | Grant or award · Stock Option (right to buy) | +60,331 | 60,331 | ||
| 2017-07-25 | Shanafelt Armen Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-07-25 | Winder Caleb Maxfield Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-07-25 | Kapnick Scott Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-07-25 | Morrison Jodie Pope Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-07-25 | Gallagher Brian M. Jr. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-07-05 | Kapnick Scott Director | Purchase | +66,666 | $15.00 | $1000K | 66,666 |
| 2017-07-05 | Apple Tree Partners II - Annex, L.P. 10% owner | Conversion | +655,797 | 655,797 | ||
| 2017-07-05 | Apple Tree Partners II - Annex, L.P. 10% owner | Conversion · Series E Preferred Stock | −3,489,740 | 0 | ||
| 2017-07-05 | Apple Tree Partners II - Annex, L.P. 10% owner | Conversion · Series E-1 Preferred Stock | −3,026,920 | 0 | ||
| 2017-07-05 | APPLE TREE PARTNERS II LP 10% owner | Conversion | +18,771 | 19,022 | ||
| 2017-07-05 | APPLE TREE PARTNERS II LP 10% owner | Conversion | +1,780,564 | 1,799,586 | ||
| 2017-07-05 | APPLE TREE PARTNERS II LP 10% owner | Conversion · Series A Preferred Stock | −1,250,000 | 0 | ||
| 2017-07-05 | APPLE TREE PARTNERS II LP 10% owner | Conversion · Series A-1 Preferred Stock | −615,384 | 0 | ||
| 2017-07-05 | APPLE TREE PARTNERS II LP 10% owner | Conversion · Series B Preferred Stock | −3,706,056 | 0 | ||
| 2017-07-05 | APPLE TREE PARTNERS II LP 10% owner | Conversion · Series C-1 Preferred Stock | −2,967,025 | 0 | ||
| 2017-07-05 | APPLE TREE PARTNERS II LP 10% owner | Conversion · Series C-2 Preferred Stock | −4,238,607 | 0 | ||
| 2017-07-05 | APPLE TREE PARTNERS II LP 10% owner | Conversion · Series D Preferred Stock | −6,781,770 | 0 | ||
| 2017-07-05 | Shanafelt Armen Director | Conversion | +844,987 | 844,987 | ||
| 2017-07-05 | Shanafelt Armen Director | Purchase | +250,000 | $15.00 | $3.8M | 1,094,987 |
Page 12 of 16 · 320 trades